People News

Cardinal Health Promotes Barrett to CEO

George Barrett has been elected to the board of directors at Cardinal Health and will serve as chairman and CEO. The company said Barrett took over after the spinoff of its medical device segment, CareFusion Corp., was completed on Aug. 31.

Barrett has served as vice chairman and CEO of the Dublin, Ohio-based company’s Healthcare Supply Chain Services segment since joining Cardinal Health in January 2008. He replaces R. Kerry Clark, who retired after the spinoff.

“I want to thank Kerry for his clear vision and leadership during his tenure as chairman and CEO,” said Richard Notebaert, a Cardinal Health director since 1999. “His legacy begins with the repositioning of Cardinal Health to better serve our hospital and pharmacy customers and culminated in the spinoff of CareFusion–enabling two companies to better serve their customers, employees and shareholders. We wish him all the best in his next chapter of life.”
 

Barrett

Barrett spent 10 years with Israel-based Teva Pharmaceutical Industries Limited before joining Cardinal Health. During his tenure at Teva, he held various positions, including executive vice president, global pharmaceutical markets, and president and CEO of Teva North America, based in North Whales, Pa.

Glenn A. Britt, chairman, president and CEO of New York, N.Y.-based Time Warner Cable, also was named to Cardinal’s board, effective Oct. 1. Britt joined Time Inc. in 1972 and held finance positions of increasing responsibility including treasurer and chief financial officer. After the merger of Time Inc. and Warner Communications, Britt was named treasurer of Time Warner Inc. and became executive vice president in 1990. Britt also has held the positions of president and chief executive of Time Warner Cable prior to his current role.

 

Ex-AngioDynamics CEO Takes Helm of Delcath Systems Inc.

Delcath Systems Inc. has appointed Eamonn Hobbs, co-founder of Queensbury, N.Y.-based AngioDynamics Incorporated, as president and CEO, according to the firm

Hobbs

Hobbs replaces Richard Taney as head of the New York, N.Y.-based drug delivery system maker. Taney will continue to serve on the company’s board of directors.

Delcath’s medical devices focus on cancer treatments. The company is testing a new system for delivering drugs to treat liver cancer.

“Eamonn is a proven leader with ex-tensive experience in all aspects of medical device commercialization,” said Dr. Harold Koplewicz, Delcath’s board chairman.

Delcath has accumulated $45.8 million of net losses since its 1988 incorporation. In the last fiscal year, the company posted a net loss of $6.9 mill-ion, or 27 cents per diluted share.

“We have had no revenue to date, a substantial accumul-ated deficit, recurring operating losses and negative cash flow,” the company said in its latest annual report, issued earlier this year.

Hobbs stepped down from his role as president and CEO at AngioDynamicsin March.

In related news, AngioDynamics, which provides medical devices used by in-terventional radiologists, surgeons and other doctors for the minimally-invasive treatment of cancer and peripheral vascular disease, has appointed Shawn P. McCarthy as senior vice president and general manager of the company’s peripheral vascular business unit.

McCarthy has worked for New Brunswick, N.J.-based Johnson & Johnson for the last 10 years. He began his career there in 1998 as a product director for Cordis Corporation, a unit of J&J.

For online exclusive People news, visithttp://www.mpo-mag.com/articles/2009/09/online-exclusive-people-news.